已收盤 11-20 16:00:00 美东时间
-0.080
-5.67%
Altimmune, Inc. announced that its management will participate in a fireside chat at the 9th Annual Evercore Healthcare Conference on December 1, 2026, at 3:25 p.m. ET. A webcast of the event will be available on the company's website. Altimmune is developing pemvidutide, a balanced 1:1 glucagon/GLP-1 dual receptor agonist, for serious liver diseases. The drug is in late-stage clinical development for metabolic dysfunction-associated steatohepati...
11-19 13:00
11月17日,iShares Diversified Alternatives(ALT)收跌5.17%,报1.56美元,成交额958.3万美元,市值3.03亿美...
11-17 07:22
今日重点评级关注:Canaccord Genuity:维持Fractyl Health"买入"评级,目标价从39美元升至40美元;HC Wainwright & Co.:维持Fractyl Health"买入"评级,目标价从8美元升至24美元
11-16 20:14
B. Riley Securities analyst William Woods reiterates Altimmune (NASDAQ:ALT) with a Buy and lowers the price target from $13 to $11.
11-13 22:19
Altimmune shares are trading lower after the company reported worse-than-expected Q3 financial results.
11-12 22:44
Altimmune (NASDAQ:ALT) reported quarterly losses of $(0.15) per share which missed the analyst consensus estimate of $(0.14) by 15.38 percent. This is a 28.57 percent increase over losses of $(0.21) per share from the same period last year. The company reported quarterly sales of $1.000 which missed...
11-12 20:40
Significant reductions across non-invasive measures of liver fat, inflammation and fibrosis observed at 48 weeks of pemvidutide treatment, with generally favorable tolerability profile Publication of results provides further validation for the balanced 1:1 glucagon/GLP-1 dual receptor agonist prof...
11-12 20:22
11月10日,iShares Diversified Alternatives(ALT)收涨1.92%,报2.12美元,成交额935.04万美元,市值4.12亿...
11-10 07:14
Altimmune, Inc. will report its third quarter 2026 financial results on November 12, 2026. The company will host a conference call at 8:30 a.m. ET on the same day to discuss the results and provide a business update. The call will be webcast live on Altimmune’s Investor Relations website. Participants can register here to receive dial-in numbers and a unique PIN. A replay will be available on the website for up to three months. Altimmune is devel...
11-05 13:00
11月3日,iShares Diversified Alternatives(ALT)收跌0.98%,报2.02美元,成交额558.6万美元,市值3.93亿美元...
11-03 07:13